NVAX Novavax Inc

$NVAX Option Friday, I thought the fun and games were over. Wow. Lot of nitwit analysis out there from the professionals. Drop from a perfect storm of negativity. Was it the false fraudulent tip ranks article? Was it just the biotech sell off and Novavax a member? Was it Shah selling? Was it Citi with a Sell rating ? Was it Shorts and market makers taking advantage ? We don’t know, could be all of them. Good news is , every single one of those reasons is a nothing burger. My classic 3 for biotechs the same. The science hasn’t changed! The fundamentals hasn’t changed! The technical pattern is still in a breakout , still an expanding ribbon . First Support held firmly 11.14-11.19, next support 10.43. I personally bought more and posted that right in the middle of the sell frenzy at 11.19 because all of the reasons are total bull. Next week the world vaccine conference, Novavax going to shine like a newborn star. 3rd qtr Revenue beat and revision upward. Multiple probable catalyst’s

$NVAX Can anyone blame him? Shah has the money and a significant remaining stake, but why keep fighting a Board that has shown so little urgency in turning CIC, Matrix-M, and Novavax’s other assets into meaningful partnerships and shareholder value? If a major holder is stepping back, investors have to ask who is holding management accountable. He still owns a significant position, but I would not be surprised if he continues trimming rather than wait indefinitely for this Board to deliver. Shame on the CEO and Board. Shareholders deserve urgency, execution, and accountability—not more waiting.

$NVAX IMO, THE TIPRANKS ARTICLE WAS FROM 2024 RE: FDA. NOW THAT WE KNOW THE TRUTH THAT IT WAS FALSE AND THEY ARE FULL STEAM AHEAD (STILL) WITH COVID/ FLU ( AND STAND-ALONE FLU VACCINE), IMO, WE ARE BACK TO $13+ / PPS MONDAY.

$NVAX You are soon going to see a convergence of material events the likes of which have never been seen! NIH cancer initiative inclusion Serum Institute of India CIC Sanofi CIC Phase 3 and subsequent approval Covid total sales numbers Pfizer’s Contract area disclosure Secret MTA revealed Secret MTA translated to contract Possibly BioNTech using Matrix M through Pfizer contract for NIH cancer initiative Other MTAs C. Diff My favorite that Moderna actually will use Matrix M in separate vial to be mixed on site for personalized cancer vaccine. You will never experience a stock with this upward trajectory ever again but, you will chase the high you get from it for the rest of your fucking life. It wil forever be your dragon.

$NVAX look at Novavax forecast for the year. $235-275m. As clearly seen its without milestones and royalties from Sanofi. Using the midpoint of GAAP expenses ($390 million) and the midpoint of core Adjusted Total Revenue ($255 million), Novavax has a baseline GAAP revenue-to-expense gap of roughly $135 million If Novavax will get the $125 cic phase 3 milestone they will be at 135-125=10 million deficit for 2026. If sanofi will sell $50M covid vaccine in 2026 Novavax will get $10M and break even. Anything above will make novavax profitable for 2026. 2 years ahead of 2028 forecast

$NVAX <<Matrix M will be the focal point at the World Vaccine Congress due to its ability to "set the stage" for vaccine antigens, generating a vastly superior immune profile compared to traditional aluminum salts. Matrix M acts on both the immediate and long-term cellular responses, making it exceptionally powerful for complex or mutating diseases. Innate Immunity Triggers local cell recruitment and lysosomal membrane permeabilization (LMP). Forces rapid activation of innate immune cells at the injection site and fast-tracks antigen delivery to draining lymph nodes. neutralizing antibodies that exhibit "epitope spreading”, meaning the body learns to recognize multiple areas. central to future public health planning. At current and upcoming iterations of the World Vaccine Congress, Novavax actively showcases Matrix-M licensing opportunities to drive next-generation immunotherapies in oncology.>>

$NVAX SEC hello? A fraudulant article gets posted about something that happened 2 years ago and was resolved ages ago and the stock gets hit like this just as a gamma squeeze is looking possible and the MM's are defending 13 with their lives. This is straight up fraud. Its talking about the phase 2 trial. Both the CIC and Flu went to Phase 3 after this was resolved years ago.

$NVAX Shitty weekly candle + rejection at 61.80% fibo retracement. That support #3 will be around $11.00 next week. Better for bulls if that level holds ( give or take ). Plus bearish crossdown on weekly stochastic. ... GL guys ...

$NVAX this didn’t drop just because Shah, and old piece of news from 2023 trial and all of a sudden a halt in 2024 they covered their tracks. The hit peace to me is a signal type of deal It’s old news, don’t tell me they don’t do that. We are dealing with lowlife degenerates who want to shares cheap. All you goofs shorting the shit out of it and reading this 99% of us aren’t selling 🖕🏾🐷’s

$NVAX Here's a brief, bullet-point outline confirming Shah's behind-the-scenes tactics after rigorously reviewing the data from SEC Schedule 13D/A (Amendment 8) [IMO]: ○Unshackled by the SEC: Eliminating his registered advisor status (Form ADV-W) and switching from 13D (activist) to 13G (passive investor) frees Shah from the draconian legal restrictions on insider trading. This gives him complete freedom to trade as news of AI oncology breaks. ○Forced restructuring, not panic: The sale of 2.87 million shares on October 5th was a technical requirement to close the old fund (Shah Capital Fund LLC) and settle with existing investors before transitioning to a family-owned structure. ○Personal Equity Spin-Off: Shah transferred the majority of his shares to the newly formed entity Himanshu Shah Family Office LLC, entrusting this company with his most valuable, private family assets. Best Longs

$NVAX Closing out the weekly session with absolute focus on the structural math. The short desks used a temporary regulatory detour to hunt emotional stop-losses, but they have failed to break the baseline consolidation floor. A routine protocol request from 2023 data does not alter our multi-billion dollar partner alliances or the generational value of the Matrix-M technology moat. The float remains incredibly tight, the shorts are deeply trapped, and the real catalyst window opens next week. Hold the clear vision.

$NVAX does anyone know if this event today with the Novavax presentation is streaming live or available anywhere for replay after ? - thanks in advance.

$NVAX The stock didnt have sufficient strength to overcome the resistance between 13.30-13.50. Naturally Options sellers are motivated to kill the abundance of call options. We are within channel range on a big red market day. All in a days work for the market makers. The bullish trend continues.

$NVAX My take on the options chain: October 23 is the key near-term expiration. After that, weekly call open interest drops significantly, while the big January positions remain. If Novavax delivers positive news in late October or November, a breakout above $13.40 could trigger a serious repricing. Above $15, January calls become increasingly relevant. Above $20, dealer hedging could potentially amplify the move, depending on their positioning. I see absolutely no compelling reason why options alone should keep NVAX trapped at $12–13. And if Jacobs finally delivers a MAJOR strategic deal? Fundamentals could overwhelm the entire options setup.

$NVAX Shah 13G Filing is really a non-event. He trades around his Core Position like most people, Here! He sold some shares after Sanofi deal, bough some more after CB 2025 transaction before the proxy fight and sold some shares recently. His Average Cost is below mid eights. Institutional holding is around 76% per 13D/F/Gs and substantially higher on YearOYear basis. Company is working w/ Sanofi, Pfizer, Takeda, Serum Ins of India and Top BigPharmas -- Jacobs' Tone has changed -- Listen to recent Conf Calls : Cantor/Citi! Above BPs won't be working with Nova if Platforms weren't safe/effective! Sanofi wouldn't put its name behind Nova's Products if they didn't meet its 'high' standards. Current Market Cap is a fraction of Actual R&D/SG&A costs of recent years and value proposition is huge! Shah's position holding is around $120M -- 4th place after Vanguard, Blackrock and StStreet. Got Nova!

$NVAX Pfizer IP and "Stealth Mode" Regulatory Pathways , When a company like Pfizer explores a major tech hybrid (mRNA/LNP + a foreign saponin adjuvant), they keep the preclinical data under strict lock and key until patents are filed globally. Public disclosure only happens when they transition into a Phase I clinical trial or present a closed-door abstract at an event like the World Vaccine Congress. This is a highly sophisticated convergence of mechanical cell biology (LMP) and nanotechnology. It solves the biggest dirty secret of mRNA vaccines, up to 90% of the injected mRNA gets destroyed inside the lysosome before it ever gets to make an antigen. Breaking that bubble change the safety profile of vaccines entirely.

$NVAX Nova needs to break the equity SWAPs by HFs just like Moderna did last summer then Nothing works : CB, Downgrades, etc. It's similar to Moderna's recent CB w/ Capped Call Option but in reverse. So to Hedge or protect their SHORT position they enter into Equity SWAPs or what they call TRS to create Synthetic Positions with investments banks or prime brokers to go go around short selling restrictions or disclosure agreement. Once it breaks the chain(s) then it flies like Moderna because mRNA got by their 'Instruction Sets' Balls and nothing like CB, Downgrades works while they're bleeding Billions from their leveraged short positions 😁

$NVAX The Convertible Bond [The Final Boss] with another punch to the throat. Turdvax back on the canvas.

$NVAX That's kinda the point, isn't it? It's easy to forget that only a few weeks ago we struggled to even break $10 and now, while we're below the recent highs, we have been (so far) trading above $11.11, which used to be a huge ceiling for us. It currently (🙏) appears to be the new floor. These things take time and patience through a ton of volatility.

$NVAX I honestly believe we will be green by the close. Absolutely zero negative news out this morning ... absolutely nothing has changed from yesterday or the day before or before that. The ONLY change I can see is that TODAY (imo) is one heck of a buying opportunity!!!! booooooooooooooooom !!!!!!!!!!!!!!!!!!!!!!!! 🔥